Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Can Fite Biopharma ADR Representing 300 Ord Shs CANF

Healthcare Biotechnology
Can Fite Biofarma Ltd is an Israel-based clinical-stage biopharmaceutical company engaged in developing orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The Company co-develop formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. It's... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NYSEAM:CANF)

60 Degrees Pharmaceuticals and Can-Fite BioPharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Accesswire 5 days ago

Can-Fite Achieves Milestone with First Patient Dosing in Pancreatic Cancer Phase IIa Clinical Trial

GlobeNewswire November 11, 2024

Can-Fite anti-Obesity Drug Namodenoson Received Patent Allowance in Australia

GlobeNewswire November 4, 2024

Significant Positive Results from Osteoarthritis Clinical Study in Dogs Treated with Piclidenoson

GlobeNewswire October 18, 2024

FDA Grants Orphan Drug Designation to Can-Fite's Namodenoson for Pancreatic Cancer

GlobeNewswire October 9, 2024

Join Can-Fite's Exclusive Live Investor Webinar and Q&A Session on October 29

GlobeNewswire October 7, 2024

Projected Income of $325M to Can-Fite Over the Next 10 Years After Vetbiolix Exercised its Option and Licensed Piclidenoson for Veterinary Osteoarthritis

GlobeNewswire September 24, 2024

Can-Fite: Pancreatic Carcinoma Phase IIa Clinical Study with Namodenoson Received Regulatory Authorization from the Israeli Ministry of Health

GlobeNewswire September 16, 2024

Can-Fite Reports First Half 2024 Financial Results & Progress in Two Pivotal Phase III Clinical Studies

GlobeNewswire August 29, 2024
View More News ››

Opinion & Analysis (NYSEAM:CANF)

Biopharma Reports Consistent 'Phase 2 Liver Fat (NASH and NAFLD) Results'

Streetwise Reports April 23, 2020

Biopharma Signs Multimillion-Dollar Deal for Key Products in China

Streetwise Reports August 8, 2018
View More Opinion ››

Bullboard Posts (NYSEAM:CANF)

Can-Fite Reports First Half 2024 Financial Results & Progres

BREAKING NEWS: $CANF Can-Fite Reports First Half 2024 Financial Results & Progress in Two Pivotal Phase III Clinical StudiesRAMAT...
whytestocks - August 29, 2024

Can-Fite Updates on its Advanced Liver Cancer Pivotal Phase

NEWS: $CANF Can-Fite Updates on its Advanced Liver Cancer Pivotal Phase 3 StudyNamodenoson granted Orphan Drug and Fast track status...
whytestocks - June 5, 2024

Can-Fite to Present at the Emerging Growth Conference on Jul

News; $CANF Can-Fite to Present at the Emerging Growth Conference on July 13, 2023Can-Fite invites individual and institutional...
whytestocks - July 7, 2023

Can-Fite Reports First Quarter 2023 Financial Results & Prov

Breaking News: $CANF Can-Fite Reports First Quarter 2023 Financial Results & Provides Clinical UpdateCan-Fite BioPharma Ltd . (NYSE...
whytestocks - June 1, 2023

CANF - Isn't Done Yet

<< View Post To Watch Video >>
HDavis - December 20, 2021

CANF - Huge News

<< View Post To Watch Video >>
HDavis - December 20, 2021
View more Bullboard ››

Cascadia Minerals Ltd

Cascadia Minerals Ltd

Cascadia is a Canadian junior mining company focused on exploring for copper and gold in the Yukon and British Columbia ...
View More »